{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T12:41:12Z","timestamp":1698410472524},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00108-023-01596-w","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T11:02:17Z","timestamp":1697713337000},"page":"1077-1084","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostik und Therapie der h\u00e4mophagozytischen Lymphohistiozytose","Diagnostics and treatment of hemophagocytic lymphohistiocytosis"],"prefix":"10.1007","volume":"64","author":[{"given":"Dennis A.","family":"Eichenauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"B\u00f6ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"1596_CR1","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e\u00a0P, Horne\u00a0A, Hines\u00a0M et\u00a0al (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133:2465\u20132477. https:\/\/doi.org\/10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"1596_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00432-020-03139-4","volume":"146","author":"S Birndt","year":"2020","unstructured":"Birndt\u00a0S, Schenk\u00a0T, Heinevetter\u00a0B et\u00a0al (2020) Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a\u00a0nationwide German registry. J\u00a0Cancer Res Clin Oncol 146:1065\u20131077. https:\/\/doi.org\/10.1007\/s00432-020-03139-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"1596_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05271-w","author":"A Abdelhay","year":"2023","unstructured":"Abdelhay\u00a0A, Mahmoud\u00a0A, Mostafa\u00a0M et al (2023) Delay in treatment of adult hemophagocytic lymphohistiocytosis is associated with worse in-hospital outcomes. Ann Hematol. https:\/\/doi.org\/10.1007\/s00277-023-05271-w","journal-title":"Ann Hematol"},{"key":"1596_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/bjh.18617","volume":"201","author":"D Kuron","year":"2023","unstructured":"Kuron\u00a0D, Voran\u00a0JC, von Samson-Himmelstjerna\u00a0FA et al (2023) Epidemiology of haemophagocytic lymphohistiocytosis at the population level in Germany. Br J Haematol 201:285\u2013289. https:\/\/doi.org\/10.1111\/bjh.18617","journal-title":"Br J Haematol"},{"key":"1596_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/joim.13432","volume":"291","author":"J West","year":"2022","unstructured":"West\u00a0J, Card\u00a0TR, Bishton\u00a0MJ et al (2022) Incidence and survival of haemophagocytic lymphohistiocytosis: A\u00a0population-based cohort study from England. J\u00a0Intern Med 291:493\u2013504. https:\/\/doi.org\/10.1111\/joim.13432","journal-title":"J Intern Med"},{"key":"1596_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.03.006","author":"MR Hines","year":"2023","unstructured":"Hines\u00a0MR, Knight\u00a0TE, McNerney\u00a0KO et al (2023) Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome. Transplant Cell Ther. https:\/\/doi.org\/10.1016\/j.jtct.2023.03.006","journal-title":"Transplant Cell Ther"},{"key":"1596_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1080\/10428194.2021.1881507","volume":"62","author":"A Major","year":"2021","unstructured":"Major\u00a0A, Collins\u00a0J, Craney\u00a0C et al (2021) Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T\u2011cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and review of the literature. Leuk Lymphoma 62:1765\u20131769. https:\/\/doi.org\/10.1080\/10428194.2021.1881507","journal-title":"Leuk Lymphoma"},{"key":"1596_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00063-021-00781-9","volume":"116","author":"DA Eichenauer","year":"2021","unstructured":"Eichenauer\u00a0DA, Lachmann\u00a0G, La Ros\u00e9e\u00a0P (2021) Die h\u00e4mophagozytische Lymphohistiozytose bei kritisch kranken Patienten. Med Klin Intensivmed Notfallmed 116:129\u2013134. https:\/\/doi.org\/10.1007\/s00063-021-00781-9","journal-title":"Med Klin Intensivmed Notfallmed"},{"key":"1596_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bjh.14144","volume":"174","author":"E Brisse","year":"2016","unstructured":"Brisse\u00a0E, Matthys\u00a0P, Wouters\u00a0CH (2016) Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol 174:175\u2013187. https:\/\/doi.org\/10.1111\/bjh.14144","journal-title":"Br J Haematol"},{"key":"1596_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter\u00a0JI, Horne\u00a0A, Arico\u00a0M et al (2007) HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"1596_CR11","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet\u00a0L, Galicier\u00a0L, Lambotte\u00a0O et\u00a0al (2014) Development and validation of the HScore, a\u00a0score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66:2613\u20132620. https:\/\/doi.org\/10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"1596_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004581","author":"C Knaak","year":"2020","unstructured":"Knaak\u00a0C, Schuster\u00a0FS, Nyvlt\u00a0P et\u00a0al (2020) Treatment and mortality of hemophagocytic lymphohistiocytosis in adult critically ill patients: a\u00a0systematic review with pooled analysis. Crit Care Med. https:\/\/doi.org\/10.1097\/CCM.0000000000004581","journal-title":"Crit Care Med"},{"key":"1596_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0140-6736(06)68232-9","volume":"367","author":"JI Henter","year":"2006","unstructured":"Henter\u00a0JI, Chow\u00a0CB, Leung\u00a0CW, Lau\u00a0YL (2006) Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet 367:870\u2013873. https:\/\/doi.org\/10.1016\/S0140-6736(06)68232-9","journal-title":"Lancet"},{"key":"1596_CR14","unstructured":"https:\/\/www.onkopedia.com\/de\/onkopedia\/guidelines\/haemophagozytische-lymphohistiozytose-hlh\/@@guideline\/html\/index.html. Zugegriffen: 15, Aug. 2023"},{"key":"1596_CR15","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood-2022-164496","volume":"140","author":"D Zhou","year":"2022","unstructured":"Zhou\u00a0D, Huang\u00a0X, Li\u00a0X et al (2022) Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed hemophagocytic lymphohistiocytosis: a\u00a0prospective, single-center, single-arm, phase\u00a02 clinical trial. Blood 140:2620\u20132621. https:\/\/doi.org\/10.1182\/blood-2022-164496","journal-title":"Blood"},{"key":"1596_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13613-022-01075-9","volume":"12","author":"T Dupont","year":"2022","unstructured":"Dupont\u00a0T, Darmon\u00a0M, Mariotte\u00a0E et al (2022) Etoposide treatment in secondary hemophagocytic syndrome: impact on healthcare-associated infections and survival. Ann Intensive Care 12:101. https:\/\/doi.org\/10.1186\/s13613-022-01075-9","journal-title":"Ann Intensive Care"},{"key":"1596_CR17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1182\/blood.2021012764","volume":"139","author":"A Zoref-Lorenz","year":"2022","unstructured":"Zoref-Lorenz\u00a0A, Murakami\u00a0J, Hofstetter\u00a0L et al (2022) An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood 139:1098\u20131110. https:\/\/doi.org\/10.1182\/blood.2021012764","journal-title":"Blood"},{"key":"1596_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/TCRM.S155488","volume":"14","author":"S Zhou","year":"2018","unstructured":"Zhou\u00a0S, Qiao\u00a0J, Bai\u00a0J et al (2018) Biological therapy of traditional therapy-resistant adult-onset still\u2019s disease: an evidence-based review. Ther Clin Risk Manag 14:167\u2013171. https:\/\/doi.org\/10.2147\/TCRM.S155488","journal-title":"Ther Clin Risk Manag"},{"key":"1596_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/ard-2022-223739","volume":"82","author":"F De Benedetti","year":"2023","unstructured":"De Benedetti\u00a0F, Grom\u00a0AA, Brogan\u00a0PA et\u00a0al (2023) Efficacy and safety of emapalumab in macrophage activation syndrome. Ann Rheum Dis 82:857\u2013865. https:\/\/doi.org\/10.1136\/ard-2022-223739","journal-title":"Ann Rheum Dis"},{"key":"1596_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26668","author":"S Priyadarshini","year":"2022","unstructured":"Priyadarshini\u00a0S, Harris\u00a0A, Treisman\u00a0D et al (2022) Hemophagocytic lymphohistiocytosis secondary to \u3008scp\u3009CAR-T\u3008\/scp\u3009 cells: Update from the \u3008scp\u3009FDA\u3008\/scp\u3009 and Vizient databases. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.26668","journal-title":"Am J Hematol"},{"key":"1596_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13045-023-01434-4","volume":"16","author":"J West","year":"2023","unstructured":"West\u00a0J, Stilwell\u00a0P, Liu\u00a0H et al (2023) 1\u2011year survival in haemophagocytic lymphohistiocytosis: a\u00a0nationwide cohort study from England 2003\u20132018. J\u00a0Hematol Oncol 16:56. https:\/\/doi.org\/10.1186\/s13045-023-01434-4","journal-title":"J Hematol Oncol"},{"key":"1596_CR22","first-page":"330","volume":"10","author":"G Kumar","year":"2020","unstructured":"Kumar\u00a0G, Hererra\u00a0M, Patel\u00a0D et al (2020) Outcomes of adult critically ill patients with hemophagocytic lymphohistiocytosis in united states-analysis from an administrative database from 2007 to 2015. Am J Blood Res 10:330\u2013338","journal-title":"Am J Blood Res"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01596-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-023-01596-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01596-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T08:03:05Z","timestamp":1698307385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-023-01596-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1596"],"URL":"https:\/\/doi.org\/10.1007\/s00108-023-01596-w","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"8 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>D.A.\u00a0Eichenauer<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Oberarzt Klinik I f\u00fcr Innere Medizin, Uniklinik K\u00f6ln | Mitgliedschaften: DGHO, DGIIN und<b> B.\u00a0B\u00f6ll<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Oberarzt Uniklinik K\u00f6ln H\u00e4matologie, Internistische Intensivmedizin | Mitgliedschaften: DGIM, DGHO, DGIIN.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}